Outpatient Surgery Magazine - Subscribers

Get Patients to Pay Up - May 2015 - Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/510361

Contents of this Issue

Navigation

Page 20 of 170

2 1 M AY 2 0 1 5 | O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E • Emend (aprepitant) 80 mg oral or film or 150 mg IV. Emend antagonizes the NK1 receptors and can prevent vomiting from a single dose. It works for 48 hours. • Ativan (lorazepam) 2 mg sublingual. Ativan is a sedative that is most generally used to treat anxiety, but also works well to treat post-oper- ative nausea and vomiting. It is known by oncologists as a treatment to reduce nausea, vomiting and anxiety in patients undergoing chemotherapy. • Zyprexa (olanzapine) 5 mg po. When everything has failed, patients with intractable nausea and vomiting undergoing chemotherapy swear by this well-known anti-psychotic drug's antiemetic properties. The mechanism remains unclear, but it appears that olanzapine blocks multiple types of receptors that induce both nausea and vomit- ing. When all else fails, Zyprexa might be worth a try. John Hsu, MD Presbyterian Hospital Whittier, Calif. shjhshjh@gmail.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Subscribers - Get Patients to Pay Up - May 2015 - Outpatient Surgery Magazine